We are aiming to innovate PET diagnostic imaging by transforming blood flow quantification.
MedTrace Pharma A/S was founded with the belief that we can improve diagnostic accuracy in PET perfusion examinations to the benefit of patients globally. It is our ambition to make 15O-water PET clinically available for all cardiac patients and to help usher in a new era in diagnostic medicine.